Please assess the completion status of the following clinical trial:

Trial Title: Simvastatin For Intracerebral Hemorrhage Study

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient with CT evidence of ICH admitted within 24 hours of onset of symptoms.~Exclusion Criteria:~* Age \< 18 or \> 85~* Admission Glasgow Coma Score (GCS) \< 6~* ICH volume \< 10 cc~* ICH secondary to trauma, aneurysm, Arterio-Venous Malformation (AVM), tumor or post surgical~* Multiple ICH~* Associated Subdural hematoma or significant Subarachnoid hemorrhage~* History of prior neurologic disease with modified Rankin Scale (mRS) \> 1~* Hematoma evacuation, hemicraniectomy, clot lysis~* Myopathy~* Active Liver disease~* Pregnancy~* Statin allergy~* Patients on statins prior to admission~* Patients with an acute indication for statin therapy (Unstable angina)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- I (Type: EXPERIMENTAL): Simvastatin Group
- II (Type: PLACEBO_COMPARATOR): Placebo Group

Based on this trial design, predict the completion outcome and termination type (if applicable).